ZFP36L2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.998600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.526600E-01
Normal-vs-Stage2
9.910400E-01
Normal-vs-Stage3
5.820600E-01
Normal-vs-Stage4
2.819000E-01
Stage1-vs-Stage2
4.309800E-01
Stage1-vs-Stage3
7.764600E-01
Stage1-vs-Stage4
3.527600E-02
Stage2-vs-Stage3
3.274600E-01
Stage2-vs-Stage4
2.008400E-01
Stage3-vs-Stage4
1.331580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.935800E-01
Normal-vs-AfricanAmerican
6.266000E-01
Normal-vs-Asian
5.700200E-01
Caucasian-vs-AfricanAmerican
2.551800E-01
Caucasian-vs-Asian
3.943400E-01
AfricanAmerican-vs-Asian
1.646620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.765000E-01
Normal-vs-Female
8.981800E-01
Male-vs-Female
8.521200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.424000E-01
Normal-vs-Age(41-60Yrs)
8.574200E-01
Normal-vs-Age(61-80Yrs)
7.597400E-01
Normal-vs-Age(81-100Yrs)
9.538200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.815600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.281200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.870000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.643600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.977600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.893600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.046400E-01
Normal-vs-Daily Drinker
9.582800E-01
Normal-vs-Weekly Drinker
8.411000E-01
Normal-vs-Occasional Drinker
4.816600E-01
Normal-vs-Social Drinker
6.573400E-01
Non Drinker-vs-Daily Drinker
9.132800E-01
Non Drinker-vs-Weekly Drinker
5.654000E-01
Non Drinker-vs-Occasional Drinker
9.617900E-02
Non Drinker-vs-Social Drinker
2.972600E-01
Daily Drinker-vs-Weekly Drinker
6.193000E-01
Daily Drinker-vs-Occasional Drinker
1.933600E-01
Daily Drinker-vs-Social Drinker
4.385200E-01
Weekly Drinker-vs-Occasional Drinker
6.050000E-01
Weekly Drinker-vs-Social Drinker
9.141600E-01
Occasional Drinker-vs-Social Drinker
5.685800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.212800E-01
Normal-vs-Grade 2
6.440000E-03
Normal-vs-Grade 3
3.219600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.481000E-03
Grade 1-vs-Grade 3
1.563740E-02
Grade 1-vs-Grade 4
2.212800E-01
Grade 2-vs-Grade 3
7.344400E-01
Grade 2-vs-Grade 4
6.440000E-03
Grade 3-vs-Grade 4
3.219600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.775000E-01
Normal-vs-NonDiabetic
8.589600E-01
Diabetic-vs-NonDiabetic
9.898200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.872000E-01
Normal-vs-NoPancreatitis
8.111800E-01
Pancreatitis-vs-NoPancreatitis
1.517850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.587600E-01
Normal-vs-N1
9.786800E-01
N0-vs-N1
2.596000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.453800E-01
Normal-vs-TP53-NonMutant
9.143600E-01
TP53-Mutant-vs-TP53-NonMutant
3.059000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
